Page last updated: 2024-11-01

niclosamide and Liver Neoplasms

niclosamide has been researched along with Liver Neoplasms in 8 studies

Niclosamide: An antihelmintic that is active against most tapeworms. (From Martindale, The Extra Pharmacopoeia, 30th ed, p48)
niclosamide : A secondary carboxamide resulting from the formal condensation of the carboxy group of 5-chlorosalicylic acid with the amino group of 2-chloro-4-nitroaniline. It is an oral anthelmintic drug approved for use against tapeworm infections.

Liver Neoplasms: Tumors or cancer of the LIVER.

Research Excerpts

ExcerptRelevanceReference
"Niclosamide (NIC) is an anthelmintic agent repurposed as a potent anticancer agent."5.56Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways. ( Abdel-Rahman, N; Eissa, LA; El-Karef, A; El-Sherbiny, IM; Yahia, S; Zeyada, MS, 2020)
" Oral administration of NEN to mice significantly slowed growth of genetically induced liver tumors and patient-derived xenografts, whereas niclosamide did not, coinciding with the observed greater bioavailability of NEN compared with niclosamide."5.46Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. ( Butte, AJ; Chen, B; Chua, MS; Gill, RM; Ma, L; So, S; Wei, W; Yang, B, 2017)
"Niclosamide (NIC) is an anthelmintic agent repurposed as a potent anticancer agent."1.56Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways. ( Abdel-Rahman, N; Eissa, LA; El-Karef, A; El-Sherbiny, IM; Yahia, S; Zeyada, MS, 2020)
" Oral administration of NEN to mice significantly slowed growth of genetically induced liver tumors and patient-derived xenografts, whereas niclosamide did not, coinciding with the observed greater bioavailability of NEN compared with niclosamide."1.46Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling. ( Butte, AJ; Chen, B; Chua, MS; Gill, RM; Ma, L; So, S; Wei, W; Yang, B, 2017)
"Hepatocellular carcinoma was then developed in the transgenic zebrafish."1.42Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis. ( Choi, JH; Chung, YY; Jung, IH; Lim, GL; Park, SW; Park, YN, 2015)
"Metastasis formation in colon cancer severely reduces the survival rate in patients."1.37Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer. ( Fichtner, I; Kobelt, D; Lemm, M; Sack, U; Schlag, PM; Scudiero, D; Selby, M; Shoemaker, RH; Stein, U; Walther, W, 2011)

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's7 (87.50)24.3611
2020's1 (12.50)2.80

Authors

AuthorsStudies
Zeyada, MS1
Abdel-Rahman, N1
El-Karef, A1
Yahia, S1
El-Sherbiny, IM1
Eissa, LA1
Alasadi, A1
Chen, M1
Swapna, GVT1
Tao, H1
Guo, J1
Collantes, J1
Fadhil, N1
Montelione, GT1
Jin, S1
Chien, MH1
Ho, YC1
Yang, SF1
Yang, YC1
Lai, SY1
Chen, WS1
Chen, MJ1
Yeh, CB1
Jung, IH1
Choi, JH1
Chung, YY1
Lim, GL1
Park, YN1
Park, SW1
Weng, S1
Zhou, L1
Deng, Q1
Wang, J1
Yu, Y1
Zhu, J1
Yuan, Y1
Chen, B1
Wei, W1
Ma, L1
Yang, B1
Gill, RM1
Chua, MS1
Butte, AJ1
So, S1
Helfman, DM1
Sack, U1
Walther, W1
Scudiero, D1
Selby, M1
Kobelt, D1
Lemm, M1
Fichtner, I1
Schlag, PM1
Shoemaker, RH1
Stein, U1

Other Studies

8 other studies available for niclosamide and Liver Neoplasms

ArticleYear
Niclosamide-loaded polymeric micelles ameliorate hepatocellular carcinoma in vivo through targeting Wnt and Notch pathways.
    Life sciences, 2020, Nov-15, Volume: 261

    Topics: Animals; Anthelmintics; Antineoplastic Agents; Carcinoma, Hepatocellular; Drug Carriers; Liver Neopl

2020
Effect of mitochondrial uncouplers niclosamide ethanolamine (NEN) and oxyclozanide on hepatic metastasis of colon cancer.
    Cell death & disease, 2018, 02-13, Volume: 9, Issue:2

    Topics: Animals; Antinematodal Agents; Colonic Neoplasms; Ethanolamine; Humans; Liver Neoplasms; Mice; Niclo

2018
Niclosamide, an oral antihelmintic drug, exhibits antimetastatic activity in hepatocellular carcinoma cells through downregulating twist-mediated CD10 expression.
    Environmental toxicology, 2018, Volume: 33, Issue:6

    Topics: Administration, Oral; Anthelmintics; Carcinoma, Hepatocellular; Cell Line, Tumor; Cell Movement; Dow

2018
Predominant Activation of JAK/STAT3 Pathway by Interleukin-6 Is Implicated in Hepatocarcinogenesis.
    Neoplasia (New York, N.Y.), 2015, Volume: 17, Issue:7

    Topics: Aminopyridines; Animals; Carcinoma, Hepatocellular; Cell Transformation, Neoplastic; Cyclic S-Oxides

2015
Niclosamide induced cell apoptosis via upregulation of ATF3 and activation of PERK in Hepatocellular carcinoma cells.
    BMC gastroenterology, 2016, Feb-25, Volume: 16

    Topics: Activating Transcription Factor 3; Activating Transcription Factor 4; Anthelmintics; Apoptosis; Carc

2016
Computational Discovery of Niclosamide Ethanolamine, a Repurposed Drug Candidate That Reduces Growth of Hepatocellular Carcinoma Cells In Vitro and in Mice by Inhibiting Cell Division Cycle 37 Signaling.
    Gastroenterology, 2017, Volume: 152, Issue:8

    Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Hepatocellular; Ce

2017
Niclosamide: an established antihelminthic drug as a potential therapy against S100A4-mediated metastatic colon tumors.
    Journal of the National Cancer Institute, 2011, Jul-06, Volume: 103, Issue:13

    Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Ce

2011
Novel effect of antihelminthic Niclosamide on S100A4-mediated metastatic progression in colon cancer.
    Journal of the National Cancer Institute, 2011, Jul-06, Volume: 103, Issue:13

    Topics: Animals; Anthelmintics; Antineoplastic Agents; beta Catenin; Biomarkers, Tumor; Cell Line, Tumor; Ce

2011